MTOR and ovarian cancer: Furthermore, the mammalian target of rapamycin (mTOR) pathway is overactivated in approximately 70% of ovarian cancers and regulates protein translation of cell growth regulators such as cyclin D1, hypoxia inducible factor 1α (HIF1α) and MYC, all essential for survival under cellular stress [9–11].